20 Aug 2025 Issue 6 Aug 28 Written By USMIRC FDA eliminates the RiskEvaluation and MitigationStrategies (REMS)requirements for all CAR-T• CEPHEUS Trial• Patient’s Corner• National ICE-T Conference• Clinical Challenge of theMonth USMIRC
20 Aug 2025 Issue 6 Aug 28 Written By USMIRC FDA eliminates the RiskEvaluation and MitigationStrategies (REMS)requirements for all CAR-T• CEPHEUS Trial• Patient’s Corner• National ICE-T Conference• Clinical Challenge of theMonth USMIRC
